Savvy Psychopharmacology

Ruling out delirium: Therapeutic principles of withdrawing and changing medications

Author and Disclosure Information

 

References

Related Resources

  • Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23(1):19-34.
  • U.S. Department of Veterans Affairs; Department of Defense. Effective treatments for PTSD: helping patients taper from benzodiazepines. www.va.gov/PAINMANAGEMENT/docs/OSI_6_Toolkit_Taper_Benzodiazepines_Clinicians.pdf.
  • U.S. Department of Veterans Affairs; Department of Defense. Tapering and discontinuing opioids. www.healthquality.va.gov/guidelines/Pain/cot/OpioidTaperingFactSheet23May2013v1.pdf.

Drug Brand Names
Acetaminophen/codeine Tylenol No. 3
Alprazolam Xanax
Amitriptyline Elavil
Atropine AtroPen
Benztropine Cogentin
Brompheniramine J-Tan PD
Chlordiazepoxide Librium
Chlorpheniramine Chlor-Trimeton
Chlorpromazine Thorazine
Clemastine Tavist
Clomipramine Anafranil
Clonazepam Klonopin
Clozapine Clozaril
Darifenacin Enablex
Desipramine Norpramin
Diazepam Valium
Dicyclomine Bentyl
Dimenhydrinate Dramamine
Diphenhydramine Benadryl
Doxepin Sinequan
Eszopiclone Lunesta
Fentanyl (transdermal patch) Duragesic
Flavoxate Urispas
Hydrocodone Hysingla, Zohydro
Hydromorphone Dilaudid
Hydroxyzine Atarax, Vistaril
Hyoscyamine Levsin
Imipramine Tofranil
Lorazepam Ativan
Meclizine Antivert
Methadone Dolophine
Morphine MS Contin
Nortriptyline Pamelor
Orphenadrine Norflex
Oxybutynin Ditropan
Oxycodone Oxycontin, Roxicodone
Promethazine Phenergan
Propantheline Pro-Banthene
Protriptyline Vivactil
Pyrilamine Ru-Hist-D
Scopolamine Transderm Scop
Temazepam Restoril
Thioridazine Mellaril
Tolterodine Detrol
Trihexyphenidyl Artane
Trimipramine Surmontil
Zaleplon Sonata
Zolpidem Ambien, Edluar, Intermezzo

Pages

Recommended Reading

Shorter duration of untreated psychosis key to Navy program’s approach to schizophrenia care
MDedge Psychiatry
Are you neuroprotecting your patients? 10 Adjunctive therapies to consider
MDedge Psychiatry
Managing clozapine-induced neutropenia and agranulocytosis
MDedge Psychiatry
Cannabis use, childhood trauma correlated in schizophrenia patients
MDedge Psychiatry
More evidence shows ties between early inflammation, schizophrenia risk in adulthood
MDedge Psychiatry
Choline and prevention of prevalent mental illnesses
MDedge Psychiatry
Revisiting delirious mania; Correcting an error
MDedge Psychiatry
French psychiatrist condemned for society’s deficiency
MDedge Psychiatry
Developing a personal scale for evaluating agitation on inpatient units
MDedge Psychiatry
Latuda receives FDA approval for adolescent schizophrenia treatment
MDedge Psychiatry